BMY Bristol Myers Squibb Co

Price (delayed)

$57.6

Market cap

$127.99B

P/E Ratio

N/A

Dividend/share

$1.96

EPS

-$2.24

Enterprise value

$162.13B

Bristol Myers Squibb is an American pharmaceutical company, headquartered in New York City. Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, ...

Highlights
Bristol Myers Squibb's gross profit has increased by 39% YoY and by 6% from the previous quarter
The company's revenue rose by 27% YoY and by 3.7% QoQ
Bristol Myers Squibb's equity has decreased by 25% YoY and by 2.1% from the previous quarter
The quick ratio has decreased by 8% YoY and by 7% QoQ

Key stats

What are the main financial stats of BMY
Market
Shares outstanding
2.22B
Market cap
$127.99B
Enterprise value
$162.13B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.49
Price to sales (P/S)
2.9
EV/EBIT
N/A
EV/EBITDA
24.59
EV/Sales
3.65
Earnings
Revenue
$44.38B
EBIT
-$4.13B
EBITDA
$6.59B
Free cash flow
$11.95B
Per share
EPS
-$2.24
Free cash flow per share
$5.35
Book value per share
$16.48
Revenue per share
$19.88
TBVPS
$18.9
Balance sheet
Total assets
$110.8B
Total liabilities
$73.92B
Debt
$45.16B
Equity
$36.81B
Working capital
$10.17B
Liquidity
Debt to equity
1.23
Current ratio
1.54
Quick ratio
1.16
Net debt/EBITDA
5.18
Margins
EBITDA margin
14.9%
Gross margin
75.9%
Net margin
-11.4%
Operating margin
-9.3%
Efficiency
Return on assets
-4.3%
Return on equity
-12.5%
Return on invested capital
-7.1%
Return on capital employed
-4.5%
Return on sales
-9.3%
Dividend
Dividend yield
3.4%
DPS
$1.96
Payout ratio
N/A

BMY stock price

How has the Bristol Myers Squibb stock price performed over time
Intraday
-0.36%
1 week
-1.3%
1 month
-4.24%
1 year
-5.2%
YTD
-7.14%
QTD
-2.65%

Financial performance

How have Bristol Myers Squibb's revenue and profit performed over time
Revenue
$44.38B
Gross profit
$33.68B
Operating income
-$4.11B
Net income
-$5.08B
Gross margin
75.9%
Net margin
-11.4%
Bristol Myers Squibb's gross profit has increased by 39% YoY and by 6% from the previous quarter
The company's revenue rose by 27% YoY and by 3.7% QoQ
BMY's net margin is up by 21% since the previous quarter
The net income has grown by 18% since the previous quarter

Growth

What is Bristol Myers Squibb's growth rate over time

Valuation

What is Bristol Myers Squibb stock price valuation
P/E
N/A
P/B
3.49
P/S
2.9
EV/EBIT
N/A
EV/EBITDA
24.59
EV/Sales
3.65
Bristol Myers Squibb's EPS has increased by 19% QoQ
BMY's P/B is 33% below its 5-year quarterly average of 5.2 and 3.1% below its last 4 quarters average of 3.6
Bristol Myers Squibb's equity has decreased by 25% YoY and by 2.1% from the previous quarter
The price to sales (P/S) is 28% less than the 5-year quarterly average of 4.0 and 15% less than the last 4 quarters average of 3.4
The company's revenue rose by 27% YoY and by 3.7% QoQ

Efficiency

How efficient is Bristol Myers Squibb business performance
Bristol Myers Squibb's ROA has increased by 16% from the previous quarter
The ROE has grown by 12% from the previous quarter
Bristol Myers Squibb's return on sales has increased by 2.1% QoQ

Dividends

What is BMY's dividend history
DPS
$1.96
Dividend yield
3.4%
Payout ratio
N/A
Recent dividends

Financial health

How did Bristol Myers Squibb financials performed over time
BMY's total assets is 50% greater than its total liabilities
BMY's total assets is down by 13% year-on-year
The quick ratio has decreased by 8% YoY and by 7% QoQ
BMY's debt is 23% greater than its equity
The company's debt to equity rose by 29% YoY
Bristol Myers Squibb's equity has decreased by 25% YoY and by 2.1% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.